Metabolic Syndrome and Insulin Resistance in Sodium Valproate or Carbamazepine Monotherapy: A Case-control Study
Background: Medications can increase the incidence rate of metabolic syndrome (MetS) and insulin resistance (IR). This study aimed to evaluate the effects of Carbamazepine (CBZ) or Valproate (VPA) as monotherapy on the development of MetS and IR in adult Iranian epileptic patients.Methods: In this o...
Main Authors: | Mahnaz Bayat, Nasrin Jalali, Maryam Poursadeghfard, Mohammad Hossein Dabbaghmanesh, Nahid Ashjazadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Kerman University of Medical Sciences
2021-11-01
|
Series: | Journal of Kerman University of Medical Sciences |
Subjects: | |
Online Access: | https://jkmu.kmu.ac.ir/article_91826_97358370ed05cb71b3acd1e6f8140296.pdf |
Similar Items
-
Valproate-coenzyme A conjugate blocks opening of receptor binding domains in the spike trimer of SARS-CoV-2 through an allosteric mechanism
by: Federica Maschietto, et al.
Published: (2023-01-01) -
Effects of Dose Amount for Antiepileptic Drugs on Lipid Profile of Male Rats (Rattus Norvegicus).
by: Abbas Mohsin Abbas
Published: (2019-04-01) -
Effects of Dose Amount for Antiepileptic Drugs on Lipid Profile of Male Rats (Rattus Norvegicus).
by: Abbas Mohsin Abbas
Published: (2019-04-01) -
Effects of Dose Amount for Antiepileptic Drugs on Lipid Profile of Male Rats (Rattus Norvegicus).
by: Abbas Mohsin Abbas
Published: (2019-04-01) -
Development of Insulin Resistance in Patients with Epilepsy During Valproate and Carbamazepine Monotherapy
by: Selda KESKİN GÜLER, et al.
Published: (2016-12-01)